COPENHAGEN, Denmark — Novozymes, a leader in bioinnovation, and Syngenta, one of the world’s leading agricultural companies, announced an exclusive global marketing and distribution agreement last week on the microbial-based biofungicide Taegro, a natural solution used to combat fungal diseases across various crops.
The two companies will join forces to bring Novozymes’ Taegro to farmers worldwide through Syngenta’s global organization.
“This collaboration matches Syngenta’s global market strength and leading position within fungicides and integrated solutions with Novozymes’ deep know-how on sustainable, biobased technologies,” said Thomas Videbæk, executive vice president of Novozymes. “Using technology developed by Novozymes, Syngenta will provide farmers all over the world with a biological product to help sustainably combat fungal diseases in a powerful manner.”
Taegro is a microbial fungicide based on the naturally occurring Bacillus subtilis bacterium, which is complementary to existing fungicide technology. It targets fungal diseases such as Rhizoctonia and Fusarium on fruit and vegetables, and its application is expected to be expanded to a wider portfolio of broad-acre crops such as wheat, soy and corn.
Under the terms of the agreement, Syngenta will be responsible for sales, marketing and distribution, while Novozymes will be responsible for production and registration.
Trials are planned to secure data to build on the current U.S. registration in other regions, following which the two companies aim for a global rollout.
Financial details about the agreement are not being disclosed.